investors concerned about us generic pricing pressure | nithya balasubramanian, sanford bernstein
Published 2 years ago • 602 plays • Length 15:32Download video MP4
Download video MP3
Similar videos
-
9:35
where is value in pharma pack? | nithya balasubramanian, sanford bernstein
-
8:55
pecking order for indian pharma cos | moving past u.s. pricing pressure? | nithya balasubramanian
-
13:34
pain in pharma pack? | nithya balasubramanian, sanford bernstein & a vaidheesh, former md,gsk pharma
-
12:30
is pharma ripe for re-rating? | nithya balasubramanian of sanford bernstein to et now
-
10:00
how's the generics market shaping up in pharma sector? | nithya balasubramanian | et now
-
10:22
all you need to know about thematic investing - part 1
-
7:14
aurobindo pharma - a wealth compounder in the making? find out why we like this company!
-
1:08:40
examining rated note fund structures for insurance company investors
-
7:57
sanford bernstein's nithya balasubramanian on q4 results of pharma cos & china opportunity
-
6:59
cipla vs sun pharma - is pharma ready for a turnaround? | nithya balasubramanian, sanford bernstein
-
10:05
sanford bernstein's nithya balasubramanian's take on pharma universe | bazaar morning call
-
10:11
sanford bernstein's nithya balasubramanian's take on pharma stocks amid covid-19 concerns
-
12:02
will pharma stocks rally continue? nithya balasubramanian of bernstein | business news
-
13:00
why the buzz in pharma stocks | nithya balasubramanian & kewal handa discuss
-
11:46
sanford bernstein's nithya balasubramanian shares her views on biocon, gland pharma | cnbc-tv18
-
8:49
robust q2 for indian pharma | nithya balasubramanian of sanford bernstein to et now
-
11:32
what does 2022 hold for pharma companies? | a vaidheesh & nithya balasubramanian
-
3:42
the biotech growth trust – equity proposition
-
0:30
tms ep161: palm oil, tv narendran, contact-sensitive sectors, credit score
-
0:31
technology & investor education protection